26 results on '"Brusamolino, E."'
Search Results
2. Nonmyeloablative conditioning, unmanipulated haploidentical SCT and post-infusion CY for advanced lymphomas
3. Immunochemotherapy with in vivo purging and autotransplant induces long clinical and molecular remission in advanced relapsed and refractory follicular lymphoma
4. Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT
5. A model of in vivo purging with Rituximab and high-dose AraC in follicular and mantle cell lymphoma
6. Acute myeloid leukemia (AML) having evolved from essential thrombocythemia (ET): distinctive chromosome abnormalities in patients treated with pipobroman or hydroxyurea
7. Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy
8. A sequence of immuno-chemotherapy with Rituximab, mobilization of in vivo purged stem cells, high-dose chemotherapy and autotransplant is an effective and non-toxic treatment for advanced follicular and mantle cell lymphoma
9. Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphoma
10. Managing the myelotoxicity of CHOP chemotherapy.
11. Treatment of terminal-phase chronic myelogenous leukemia with intermediate-dose cytarabine and hydroxyurea.
12. Treatment-related leukemia in Hodgkin's disease: a multi-institution study on 75 cases.
13. Chronic myelomonocytic leukemia: clinical features, cytogenetics, and prognosis in 30 consecutive cases.
14. Clinicopathologic and immunologic characteristics of non-Hodgkin's lymphomas presenting in the orbit. A report of eight cases.
15. The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia. Clinical results in 46 patients.
16. Terminal deoxynucleotidyl transferase-positive acute leukemias evolving from a myelodysplastic syndrome.
17. Risk assessment in myelodysplastic syndromes: Value of clinical, hematologic and bone marrow histologic findings at presentation.
18. Plasma cell leukemia: A report on 15 patients.
19. Chemotherapy for non-Hodgkin's lymphoma.
20. Mitoxantrone with Intermediate-or High-Dose Ara-C for Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma.
21. 46 Significant reduction of second breast cancer risk in patients treated with involved nodes radiation therapy for early stage Hodgkin's lymphoma
22. Lymphoblastic lymphoma in adult patients: Clinicopathological features and response to intensive multiagent chemotherapy analogous to that used in acute lymphoblastic leukemia
23. Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy
24. Early-stage Hodgkin's disease: Long-term results with radiotherapy alone or combined radiotherapy and chemotherapy
25. Results of CAV regimen (CCNU, Melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease
26. Adult acute lymphoblastic leukemia. Response to therapy according to presenting features in 62 patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.